ELISHA BOYD: Open Payments
NPI 1649895038 · BELLEVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$838 in 25 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $1,335 · 2025 $838
Food & beverage: $838
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 10 | $359 |
| Novo Nordisk Inc | 2 | $141 |
| ABIOMED | 1 | $113 |
| Amgen Inc. | 3 | $53 |
| Alnylam Pharmaceuticals Inc. | 2 | $47 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| SCPHARMACEUTICALS INC. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| PFIZER INC. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: LifeVest, Ozempic, Repatha, AMVUTTRA, VERQUVO, FUROSCIX, LEQVIO, VYNDAQEL.
Industry payments across IL — which companies pay providers there.
